Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Hamilton

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1980
Biosynthesis of porphyrins and related macrocycles. Part 13. Structure of the protoporphyrin isomer derived from coproporphyrinogen IV by the action of beef-liver coproporphyrinogenase: synthesis of protoporphyrin XIIIA R Battersby, A D Hamilton, E McDonald, et al.
The Journal of Biological Chemistry|January 13, 2001
The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cellsN C Crespo, J Ohkanda, T J Yen, et al.
The Journal of Surgical Research|July 27, 2001
v-Src transformation is mediated through farnesylated proteinsS Teng, J Sun, R Irby, et al.
The Journal of Biological Chemistry|March 6, 1999
The geranylgeranyltransferase I inhibitor GGTI-298 induces hypophosphorylation of retinoblastoma and partner switching of cyclin-dependent kinase inhibitors. A potential mechanism for GGTI-298 antitumor activityJ Sun, Y Qian, Z Chen, et al.
Neurosurgery|July 10, 1998
Inhibition of Ras and related G-proteins as a therapeutic strategy for blocking malignant glioma growthM Bredel, I F Pollack, J M Freund, et al.
Cell Death and Differentiation|June 12, 2002
The farnesyltransferase inhibitor, FTI-2153, inhibits bipolar spindle formation during mitosis independently of transformation and Ras and p53 mutation statusN C Crespo, F Delarue, J Ohkanda, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Aromatic analogs of arcaine inhibit MK-801 binding to the NMDA receptorT A Sharma, A J Carr, R S Davis, et al.
The Journal of Organic Chemistry|October 30, 2001
Thermodynamic aspects of dicarboxylate recognition by simple artificial receptorsB R Linton, M S Goodman, E Fan, et al.
Biochemistry|September 26, 1995
Burkitt lymphoma Daudi cells contain two distinct farnesyltransferases with different divalent cation requirementsA Vogt, J Sun, Y Qian, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitorsY Qian, J J Marugan, R D Fossum, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1980
Biosynthesis of porphyrins and related macrocycles. Part 13. Structure of the protoporphyrin isomer derived from coproporphyrinogen IV by the action of beef-liver coproporphyrinogenase: synthesis of protoporphyrin XIIIA R Battersby, A D Hamilton, E McDonald, et al.
The Journal of Biological Chemistry|January 13, 2001
The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cellsN C Crespo, J Ohkanda, T J Yen, et al.
The Journal of Surgical Research|July 27, 2001
v-Src transformation is mediated through farnesylated proteinsS Teng, J Sun, R Irby, et al.
The Journal of Biological Chemistry|March 6, 1999
The geranylgeranyltransferase I inhibitor GGTI-298 induces hypophosphorylation of retinoblastoma and partner switching of cyclin-dependent kinase inhibitors. A potential mechanism for GGTI-298 antitumor activityJ Sun, Y Qian, Z Chen, et al.
Neurosurgery|July 10, 1998
Inhibition of Ras and related G-proteins as a therapeutic strategy for blocking malignant glioma growthM Bredel, I F Pollack, J M Freund, et al.
Cell Death and Differentiation|June 12, 2002
The farnesyltransferase inhibitor, FTI-2153, inhibits bipolar spindle formation during mitosis independently of transformation and Ras and p53 mutation statusN C Crespo, F Delarue, J Ohkanda, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Aromatic analogs of arcaine inhibit MK-801 binding to the NMDA receptorT A Sharma, A J Carr, R S Davis, et al.
The Journal of Organic Chemistry|October 30, 2001
Thermodynamic aspects of dicarboxylate recognition by simple artificial receptorsB R Linton, M S Goodman, E Fan, et al.
Biochemistry|September 26, 1995
Burkitt lymphoma Daudi cells contain two distinct farnesyltransferases with different divalent cation requirementsA Vogt, J Sun, Y Qian, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitorsY Qian, J J Marugan, R D Fossum, et al.
Pageof 9